Volume 11, Issue 4 (Autumn 2014)                   ASJ 2014, 11(4): 183-188 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rafighdoust H, Mohammadi Roushandeh A, Darabi S, Mortazavi M, Rafighdoust A. Cytotoxic Effects of Digoxin on Mesenchymal Stem Cells: An in Vitro Study. ASJ. 2014; 11 (4) :183-188
URL: http://anatomyjournal.ir/article-1-105-en.html
1- Organization
2- Department of Anatomical Sciences, School of Medicine, Zahehan University of Medical Sciences, Zahedan, Iran.
Abstract:   (5448 Views)
Introduction: Cardiac glycosides such as digoxin or digitoxin are the natural products that are traditionally used to increase cardiac contractile force in patients with heart failure and cardiac arrhythmias. It has been shown that digoxin can directly inhibit the cell proliferation and lead to cell apoptosis. Present study was conducted to analyze the effect of digoxin in the cohorts of mesenchymal stem cells(MSCs) -based therapy. 
Methods: MSCs were cultured and treated with different concentrations (0.1, 0.5, 1, 5, 7, 10, 15, 20, 30 and 40 μM) of digoxin for 6, 12, 24 and 48 hours. MTT assay was performed to study cell viability and proliferation. 
Results: After 24 and 48 hours, cell viability was significantly decreased in 20, 30 and 40 μM concentrations (P<0.05), but significant decline in cell viability was observed only in 40 μM after 12 hours (P<0.05). After 6 hours, cell viability of experimental groups had no significant differences toward control group (P>0.05). 
Conclusion: It is suggested that digoxin may lead to decline in cell survival ability and increase in cell apoptosis in a dose-time dependent pattern. It is recommended to consider application of glycosoids in concurrence with stem cell therapy.
Full-Text [PDF 442 kb]   (3098 Downloads)    
Type of Study: Original |
Received: 2014/04/4 | Accepted: 2014/08/8 | Published: 2014/11/1

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb